• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎的风险:重新审视植物治疗干预的益处

Jeopardy of COVID-19: Rechecking the Perks of Phytotherapeutic Interventions.

作者信息

Saha Priyanka, Bose Subhankar, Srivastava Amit Kumar, Chaudhary Anis Ahmad, Lall Rajiv, Prasad Sahdeo

机构信息

Cancer Biology & Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, Kolkata 700032, WB, India.

Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSUI), Riyadh 11623, Saudi Arabia.

出版信息

Molecules. 2021 Nov 10;26(22):6783. doi: 10.3390/molecules26226783.

DOI:10.3390/molecules26226783
PMID:34833873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8621307/
Abstract

The novel coronavirus disease (COVID-19), the reason for worldwide pandemic, has already masked around 220 countries globally. This disease is induced by Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2). Arising environmental stress, increase in the oxidative stress level, weak immunity and lack of nutrition deteriorates the clinical status of the infected patients. Though several researches are at its peak for understanding and bringing forward effective therapeutics, yet there is no promising solution treating this disease directly. Medicinal plants and their active metabolites have always been promising in treating many clinical complications since time immemorial. Mother nature provides vivid chemical structures, which act multi-dimensionally all alone or synergistically in mitigating several diseases. Their unique antioxidant and anti-inflammatory activity with least side effects have made them more effective candidate for pharmacological studies. These medicinal plants inhibit attachment, encapsulation and replication of COVID-19 viruses by targeting various signaling molecules such as angiotensin converting enzyme-2, transmembrane serine protease 2, spike glycoprotein, main protease etc. This property is re-examined and its potency is now used to improve the existing global health crisis. This review is an attempt to focus various antiviral activities of various noteworthy medicinal plants. Moreover, its implications as prophylactic or preventive in various secondary complications including neurological, cardiovascular, acute kidney disease, liver disease are also pinpointed in the present review. This knowledge will help emphasis on the therapeutic developments for this novel coronavirus where it can be used as alone or in combination with the repositioned drugs to combat COVID-19.

摘要

新型冠状病毒病(COVID-19),这场全球大流行的起因,已经在全球约220个国家肆虐。这种疾病是由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的。不断出现的环境压力、氧化应激水平的升高、免疫力低下和营养缺乏会使感染患者的临床状况恶化。尽管为了解并提出有效的治疗方法,多项研究正在全力开展,但目前仍没有直接治疗这种疾病的有效解决方案。自古以来,药用植物及其活性代谢产物在治疗许多临床并发症方面一直很有前景。大自然提供了丰富多样的化学结构,它们单独或协同发挥多维度作用,以减轻多种疾病。它们独特的抗氧化和抗炎活性以及最小的副作用,使其成为药理学研究中更有效的候选对象。这些药用植物通过靶向各种信号分子,如血管紧张素转换酶2、跨膜丝氨酸蛋白酶2、刺突糖蛋白、主要蛋白酶等,来抑制COVID-19病毒的附着、包裹和复制。这一特性正在被重新审视,其效力现在被用于改善当前全球健康危机。本综述旨在聚焦各种值得关注的药用植物的多种抗病毒活性。此外,本综述还指出了其在预防或防止包括神经、心血管、急性肾病、肝病等各种继发性并发症方面的意义。这些知识将有助于强调针对这种新型冠状病毒的治疗进展,在抗击COVID-19时,它可以单独使用或与重新定位的药物联合使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa77/8621307/8e7e88ef8610/molecules-26-06783-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa77/8621307/aa6446fc90b6/molecules-26-06783-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa77/8621307/26bdae20b079/molecules-26-06783-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa77/8621307/8e7e88ef8610/molecules-26-06783-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa77/8621307/aa6446fc90b6/molecules-26-06783-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa77/8621307/26bdae20b079/molecules-26-06783-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa77/8621307/8e7e88ef8610/molecules-26-06783-g003.jpg

相似文献

1
Jeopardy of COVID-19: Rechecking the Perks of Phytotherapeutic Interventions.新型冠状病毒肺炎的风险:重新审视植物治疗干预的益处
Molecules. 2021 Nov 10;26(22):6783. doi: 10.3390/molecules26226783.
2
An Updated Review on Betacoronavirus Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery.贝塔冠状病毒病毒进入抑制剂的最新综述:从过去的发现中吸取教训,推进 COVID-19 药物发现。
Curr Top Med Chem. 2021;21(7):571-596. doi: 10.2174/1568026621666210119111409.
3
Insights into SARS-CoV-2: Medicinal Chemistry Approaches to Combat Its Structural and Functional Biology.深入了解 SARS-CoV-2:从药物化学角度探讨对抗其结构和功能生物学的方法。
Top Curr Chem (Cham). 2021 Apr 22;379(3):23. doi: 10.1007/s41061-021-00335-9.
4
Phytomedical compounds as promising therapeutic agents for COVID-19 targeting angiotensin-converting enzyme 2: a review.植物药化合物作为针对血管紧张素转换酶 2 的 COVID-19 有希望的治疗剂:综述。
J Pharm Pharmacol. 2024 Oct 3;76(10):1239-1268. doi: 10.1093/jpp/rgae101.
5
Repositioning of histamine H receptor antagonist: Doxepin inhibits viropexis of SARS-CoV-2 Spike pseudovirus by blocking ACE2.组胺 H 受体拮抗剂的再定位:多塞平通过阻断 ACE2 抑制 SARS-CoV-2 刺突假病毒的包膜融合。
Eur J Pharmacol. 2021 Apr 5;896:173897. doi: 10.1016/j.ejphar.2021.173897. Epub 2021 Jan 23.
6
Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2).通过中断严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白与血管紧张素转换酶2(ACE2)之间的相互作用来实现SARS-CoV-2早期进入的潜在治疗方法。
Biochem Pharmacol. 2021 Oct;192:114724. doi: 10.1016/j.bcp.2021.114724. Epub 2021 Aug 8.
7
Geraniin Inhibits the Entry of SARS-CoV-2 by Blocking the Interaction between Spike Protein RBD and Human ACE2 Receptor.橙皮苷通过阻断刺突蛋白 RBD 与人 ACE2 受体之间的相互作用来抑制 SARS-CoV-2 的进入。
Int J Mol Sci. 2021 Aug 10;22(16):8604. doi: 10.3390/ijms22168604.
8
Understanding Viral Infection Mechanisms and Patient Symptoms for the Development of COVID-19 Therapeutics.了解病毒感染机制和患者症状,以开发针对 COVID-19 的治疗方法。
Int J Mol Sci. 2021 Feb 9;22(4):1737. doi: 10.3390/ijms22041737.
9
The Ineluctable Role of ACE-2 Receptors in SARS COV-2 Infection and Drug Repurposing as a Plausible SARS COV-2 Therapy: A Concise Treatise.ACE2 受体在 SARS-CoV-2 感染中的必然作用及药物再利用作为 SARS-CoV-2 治疗的合理策略:简明论述。
Curr Mol Med. 2021;21(10):888-913. doi: 10.2174/1573405617666210204212024.
10
Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2.药用植物、植物化学物质和草药对抗包括 SARS-CoV-2 在内的病毒病原体。
Molecules. 2021 Mar 22;26(6):1775. doi: 10.3390/molecules26061775.

引用本文的文献

1
Hyperbaric Oxygen Therapy Counters Oxidative Stress/Inflammation-Driven Symptoms in Long COVID-19 Patients: Preliminary Outcomes.高压氧疗法对抗长新冠患者氧化应激/炎症驱动的症状:初步结果
Metabolites. 2023 Sep 25;13(10):1032. doi: 10.3390/metabo13101032.
2
Genome characterization, phylogenomic assessment and spatio-temporal dynamics study of highly mutated BA variants from India.印度高度突变 BA 变异株的基因组特征、系统发育评估和时空动态研究。
Indian J Med Microbiol. 2023 May-Jun;43:66-72. doi: 10.1016/j.ijmmb.2022.10.006. Epub 2022 Nov 15.

本文引用的文献

1
Potential role of medicinal plants and their constituents in the mitigation of SARS-CoV-2: identifying related therapeutic targets using network pharmacology and molecular docking analyses.药用植物及其成分在减轻新型冠状病毒肺炎方面的潜在作用:利用网络药理学和分子对接分析确定相关治疗靶点
RSC Adv. 2020 Jul 27;10(47):27961-27983. doi: 10.1039/d0ra05126h.
2
Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (M) inhibitors to unveil a hope against COVID-19.多维计算机筛选策略鉴定天然多酚类化合物作为 SARS-CoV-2 主蛋白酶(Mpro)抑制剂,以期为抗击 COVID-19 带来新希望。
Comput Biol Med. 2022 Jun;145:105452. doi: 10.1016/j.compbiomed.2022.105452. Epub 2022 Mar 26.
3
Citrus fruits are rich in flavonoids for immunoregulation and potential targeting ACE2.
柑橘类水果富含用于免疫调节和潜在靶向血管紧张素转换酶2(ACE2)的类黄酮。
Nat Prod Bioprospect. 2022 Feb 14;12(1):4. doi: 10.1007/s13659-022-00325-4.
4
Impact of COVID-19 in Liver Disease Progression.新型冠状病毒肺炎对肝脏疾病进展的影响。
Hepatol Commun. 2021 Jul;5(7):1138-1150. doi: 10.1002/hep4.1745. Epub 2021 May 31.
5
Lifestyle Adjustments in Long-COVID Management: Potential Benefits of Plant-Based Diets.长新冠管理中的生活方式调整:植物性饮食的潜在益处。
Curr Nutr Rep. 2021 Dec;10(4):352-363. doi: 10.1007/s13668-021-00369-x. Epub 2021 Sep 10.
6
Rhizomes as a Natural Source of SARS-CoV-2 Mpro Inhibitors-Molecular Docking and In Vitro Study.根茎作为严重急性呼吸综合征冠状病毒2主蛋白酶抑制剂的天然来源——分子对接与体外研究
Pharmaceuticals (Basel). 2021 Jul 29;14(8):742. doi: 10.3390/ph14080742.
7
Unravelling the Phytochemical Composition and the Pharmacological Properties of an Optimized Extract from the Fruit from L.: From Traditional Liqueur Market to the Pharmacy Shelf.解析优化后的 果实提取物的植物化学成分和药理学特性:从传统利口酒市场到药店货架。
Molecules. 2021 Jul 22;26(15):4422. doi: 10.3390/molecules26154422.
8
Efficacy of diammonium glycyrrhizinate combined with vitamin C for treating hospitalized COVID-19 patients: a retrospective, observational study.甘草酸二铵联合维生素 C 治疗住院 COVID-19 患者的疗效:一项回顾性观察研究。
QJM. 2022 Feb 21;115(2):77-83. doi: 10.1093/qjmed/hcab184.
9
Glycyrrhizic Acid: A Natural Plant Ingredient as a Drug Candidate to Treat COVID-19.甘草酸:一种作为治疗新冠肺炎候选药物的天然植物成分。
Front Pharmacol. 2021 Jul 9;12:707205. doi: 10.3389/fphar.2021.707205. eCollection 2021.
10
Rheumatological complications of Covid 19.Covid-19 相关的风湿性并发症。
Autoimmun Rev. 2021 Sep;20(9):102883. doi: 10.1016/j.autrev.2021.102883. Epub 2021 Jul 5.